A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance
Abstract Tumor-associated lncRNAs regulated by epigenetic modification switches mediate immune escape and chemoresistance in ovarian cancer (OC). However, the underlying mechanisms and concrete targets have not been systematically elucidated. Here, we discovered that methylation modifications played...
Main Authors: | Lu Chen, Wujiang Gao, Li Lin, Chunli Sha, Taoqiong Li, Qi Chen, Hong Wei, Meiling Yang, Jie Xing, Mengxue Zhang, Shijie Zhao, Wenlin Xu, Yuefeng Li, Lulu Long, Xiaolan Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13048-023-01260-9 |
Similar Items
-
Construction of a novel signature based on immune-related lncRNA to identify high and low risk pancreatic adenocarcinoma patients
by: Na Li, et al.
Published: (2023-09-01) -
Identification of prognostic immune-related lncRNAs in pancreatic cancer
by: Yan Ma, et al.
Published: (2022-11-01) -
Correction: A methylation‑ and immune‑related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance
by: Lu Chen, et al.
Published: (2024-05-01) -
Terpenoids from quinoa reverse chemoresistance in breast cancer by suppressing the stemness‐related lncRNA 667012
by: Xiaxia Fan, et al.
Published: (2025-01-01) -
LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells
by: Sun Jing, et al.
Published: (2021-12-01)